NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that revenues for its fourth quarter increased 16 percent year over year on the strength of its assays and related products as well as consumables sales.

Total revenues for the three months ended Dec. 31, 2012 were $55.5 million, up from $47.9 million in the year-ago period, and beat the consensus Wall Street estimate of $54.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.